What is CDIO stock price today?

CDIO (Cardio Diagnostics Holdings Inc) stock is trading at $1.96 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is CDIO stock going up or down today?

CDIO stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CDIO stock now?

The decision to buy CDIO depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CDIO a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CDIO based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CDIO stock overvalued or undervalued?

Use our DCF valuation calculator to determine if CDIO is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is CDIO's P/E ratio?

P/E ratio data for CDIO will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is CDIO's market cap?

CDIO (Cardio Diagnostics Holdings Inc) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is CDIO's price to book ratio?

CDIO trades at a price-to-book (P/B) ratio of 0.86, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does CDIO pay dividends?

CDIO does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is CDIO's dividend yield?

CDIO does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is CDIO stock a good long-term investment?

CDIO's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CDIO's revenue growth rate?

CDIO has shown revenue growth of -0.2% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for CDIO are available on our dashboard with complete income statement analysis.

What are the risks of investing in CDIO?

Key risks for CDIO include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CDIO compare to its competitors?

Compare CDIO to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CDIO's performance and positioning.

What is CDIO's stock price target for 2026?

Our AI model provides price targets for CDIO based on fundamental analysis: Bull case $2.55 (+30%), Base case $2.25 (+15%), Bear case $1.76 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about CDIO?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CDIO. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CDIO's next earnings report?

CDIO reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CDIO - Cardio Diagnostics Holdings Inc

NYSE * Health Care * Biotechnology

$1.96

$-0.05 (-2.49%)

About Cardio Diagnostics Holdings Inc

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

CDIO Key Statistics

Market Cap

$5.95M

P/B Ratio

0.86

EPS

$-3.71

Revenue Growth

-0.2%

Employees

How CDIO Compares to Peers

CDIO is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
CDIO(This stock)	$5.95M	N/A	-0%	0.0%	-
AMGNAmgen Inc	$187.71B	24.5	0%	0.2%	vs AMGN
GILDGilead Sciences	$173.48B	20.6	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$112.35B	28.8	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$79.71B	18.2	0%	0.3%	vs REGN
BIIBBiogen Inc	$25.83B	20.0	-0%	0.1%	vs BIIB

Cardio Diagnostics Holdings Inc Company Information

Headquarters: Illinois; U.S.A
Website: cdio.ai
Sector: Health Care
Industry: Biotechnology

About Cardio Diagnostics Holdings Inc

CDIO Key Statistics

How CDIO Compares to Peers

Cardio Diagnostics Holdings Inc Company Information

Upcoming Events for CDIO